がん診断におけるAIの市場規模、シェア、動向分析レポート：コンポーネント別、がんタイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

がん診断におけるAI市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のがん診断におけるAI市場規模は2030年までに9億9,612万米ドルに達すると推定され、2025年から2030年にかけて24.12%のCAGRで成長すると予測しています。

ヘルスケアコストの削減ニーズの高まり、ヘルスケアにおけるビッグデータの重要性の高まり、精密医療の導入の改善、ハードウェアコストの低下が成長を促進する主な要因です。

診断を含む様々なヘルスケア分野における人工知能（AI）の応用範囲の拡大、がんの有病率の上昇、公衆衛生の労働力不足の深刻化は、予測期間中にがん診断における人工知能（AI）の採用を促進すると予測される主要因の一部です。さらに、がん治療におけるAIベースのツールの応用可能性の高まりとベンチャーキャピタル投資の増加が、この技術に対する需要の急増をさらに後押ししています。

マイクロソフト、Flatiron、Therapixel、Tempusなど、市場における著名なプレイヤーの存在は、成長にプラスの影響を与えると予想されます。これらのプレーヤーは、業界における自社製品のリーチを拡大し、多様な地域での製品＆サービスの可用性を高めるために、買収、提携、事業拡大、新製品発売などの戦略を採用しています。例えば、2021年12月、マイクロソフトはCVSヘルスケアとの提携を発表し、患者が健康を改善するための革新的なソリューションを開発する一方、医療従事者が患者により良いサービスを提供するためのツールを提供します。

さらに、ヘルスケアインフラ開発のための資金提供やイニシアティブという形での政府支援の高まりは、予測期間中、技術的に先進的でコスト効率の高いデバイスの需要を促進すると予想されます。

がん診断におけるAI市場のレポートハイライト

• コンポーネント別では、ソフトウェアソリューション部門が2024年の収益シェア44.39%で市場を独占し、予測期間中最も速い成長率が見込まれます。
• がんタイプ別では、乳がんが2024年に19.41%の大きな売上シェアを占めました。
• 病院分野は2024年に56.95％の最大収益シェアで市場を独占しました。
• 北米のがん診断におけるAI市場は、2023年に54.74%の最大シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 がん診断における人工知能市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場成長要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• がん診断市場分析ツールにおける人工知能
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
• COVID-19の影響
• ケーススタディ

第4章 がん診断におけるAI市場：コンポーネントの推定・動向分析

• コンポーネント市場シェア、2024年および2030年
• セグメントダッシュボード
• 世界のがん診断におけるAI市場：コンポーネント別展望
• ソフトウェアソリューション
• ハードウェア
• サービス

第5章 がん診断におけるAI市場：がんタイプの推定・動向分析

• がんタイプ別市場シェア、2024年および2030年
• セグメントダッシュボード
• 世界のがん診断におけるAI市場：がんタイプ別展望
• 乳がん
• 肺がん
• 前立腺がん
• 大腸がん
• 脳腫瘍
• その他

第6章 がん診断におけるAI市場：最終用途の推定・動向分析

• 最終用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 世界のがん診断におけるAI市場：最終用途別展望
• 病院
• 外科センターおよび医療機関
• その他

第7章 がん診断におけるAI市場：地域の推定・動向分析、コンポーネント別、がんタイプ別、最終用途別

• 地域別市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 世界地域市場のスナップショット
• 市場規模、予測動向分析、2018年から2030年まで：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• イノベーター
• ベンダー情勢
  • EarlySign
  • Cancer Center.ai
  • Microsoft
  • FLATIRON HEALTH
  • PathAI, Inc.
  • Therapixel
  • Tempus AI, Inc.
  • Paige AI Inc.
  • Kheiron Medical Technologies Limited
  • SkinVision

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. Global AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 4. Global AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 5. Global AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 6. North America AI in cancer diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 7. North America AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 8. North America AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 9. North America AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 10. U.S. AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 11. U.S. AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 12. U.S. AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 13. Canada AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 14. Canada AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 15. Canada AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 16. Mexico AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 17. Mexico AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 18. Mexico AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 19. Europe AI in cancer diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 20. Europe AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 21. Europe AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 22. Europe AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 23. UK AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 24. UK AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 25. UK AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 26. Germany AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 27. Germany AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 28. Germany AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 29. France AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 30. France AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 31. France AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 32. Italy AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 33. Italy AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 34. Italy AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 35. Spain AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 36. Spain AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 37. Spain AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 38. Norway AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 39. Norway AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 40. Norway AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 41. Denmark AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 42. Denmark AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 43. Denmark AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 44. Sweden AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 45. Sweden AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 46. Sweden AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 47. Asia Pacific AI in cancer diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 51. Japan AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 52. Japan AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 53. Japan AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 54. China AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 55. China AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 56. China AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 57. India AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 58. India AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 59. India AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 60. Australia AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 61. Australia AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 62. Australia AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 63. South Korea AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 64. South Korea AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 65. South Korea AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 66. Thiland AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 67. Thailand AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 68. Thailand AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 69. Latin America AI in cancer diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 70. Latin America AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 71. Latin America AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 72. Latin America AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 73. Brazil AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 74. Brazil AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 75. Brazil AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 76. Argentina AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 77. Argentina AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 78. Argentina AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 79. Middle East & Africa AI in cancer diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 80. Middle East & Africa AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 81. Middle East & Africa AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 82. Middle East & Africa AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 83. South Africa AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 84. South Africa AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 85. South Africa AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 86. Saudi Arabia AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 89. UAE AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 90. UAE AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 91. UAE AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
• Table 92. Kuwait AI in cancer diagnostics market, by component, 2018 - 2030 (USD Million)
• Table 93. Kuwait AI in cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
• Table 94. Kuwait AI in cancer diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Market segmentation
• Fig. 8 Market snapshot
• Fig. 9 Segment snapshot
• Fig. 10 Competitive landscape snapshot
• Fig. 11 Market trends & outlook
• Fig. 12 PESTLE analysis
• Fig. 13 Porter's five forces analysis
• Fig. 14 AI in cancer diagnostics market: Component outlook and key takeaways
• Fig. 15 AI in cancer diagnostics market: Component movement analysis
• Fig. 16 Software solutions market, 2018 - 2030 (USD Million)
• Fig. 17 Hardware market, 2018 - 2030 (USD Million)
• Fig. 18 Services market, 2018 - 2030 (USD Million)
• Fig. 19 AI in cancer diagnostics market: Cancer type outlook and key takeaways
• Fig. 20 AI in cancer diagnostics market: Cancer type movement analysis
• Fig. 21 Breast cancer market, 2018 - 2030 (USD Million)
• Fig. 22 Lung cancer market, 2018 - 2030 (USD Million)
• Fig. 23 Prostate cancer market, 2018 - 2030 (USD Million)
• Fig. 24 Colorectal cancer market, 2018 - 2030 (USD Million)
• Fig. 25 Brain Tumor market, 2018 - 2030 (USD Million)
• Fig. 26 Others market, 2018 - 2030 (USD Million)
• Fig. 27 AI in cancer diagnostics market: End use outlook and key takeaways
• Fig. 28 AI in cancer diagnostics market: End use movement analysis
• Fig. 29 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 30 Surgical centers and medical institutes market, 2018 - 2030 (USD Million)
• Fig. 31 Others market, 2018 - 2030 (USD Million)
• Fig. 32 Regional marketplace: Key takeaways
• Fig. 33 Regional outlook, 2024 & 2030
• Fig. 34 AI in cancer diagnostics market: Region movement analysis
• Fig. 35 North America AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 36 US AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 37 Key country dynamics
• Fig. 38 Canada AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 39 Key country dynamics
• Fig. 40 Mexico AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 41 Key country dynamics
• Fig. 42 Europe AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 43 UK AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 44 Key country dynamics
• Fig. 45 Germany AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 France AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 Italy AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Spain AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 Spain AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 Norway AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Denmark AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 Sweden AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Asia Pacific AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 62 Japan AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 China AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 India AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Australia AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 South Korea AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Thailand AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 Latin America AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 75 Brazil AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 Argentina AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Middle East and Africa AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 80 South Africa AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 Saudi Arabia AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 83 Key country dynamics
• Fig. 84 UAE AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Kuwait AI in cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 87 Key country dynamics
• Fig. 88 Company categorization
• Fig. 89 Strategy mapping
• Fig. 90 Company market position analysis

AI In Cancer Diagnostics Market Growth & Trends:

The global AI in cancer diagnostics market size is estimated to reach USD 996.12 million by 2030, registering to grow at a CAGR of 24.12% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing need for lowering healthcare costs, the rising importance of big data in healthcare, improving adoption of precision medicine, and declining hardware costs are key factors driving the growth.

The increasing scope of applications of artificial intelligence (AI) in various healthcare fields, including diagnostics; the rising prevalence of cancer; and the growing shortage of public health workforce are some of the key factors anticipated to fuel the adoption of artificial intelligence (AI) in cancer diagnostics over the forecast period. In addition, the increasing applicability of AI-based tools in cancer care and the rise in venture capital investments is further driving the surge in demand for this technology.

The presence of prominent players in the market such as Microsoft, Flatiron, Therapixel, and Tempus, is anticipated to positively impact the growth. These players are adopting strategies such as acquisitions, collaborations, expansions, and new product launches to increase the reach of their products in the industry and increase the availability of their products & services in diverse geographical areas. For instance, in December 2021, Microsoft announced a partnership with CVS Health to develop innovative solutions for patients to improve their health while empowering healthcare professionals with tools to better service patients.

Furthermore, the rising government support in the form of funding and initiatives for the development of healthcare infrastructure is anticipated to drive the demand for technologically advanced and cost-efficient devices over the forecast period.

AI In Cancer Diagnostics Market Report Highlights:

• Based on component, the software solutions segment dominated the market with a revenue share of 44.39% in 2024 and is expected to witness the fastest growth rate during the forecast period.
• Based on cancer type, breast cancer had a significant revenue share of 19.41% in 2024.
• Hospital segment dominated the market with the largest revenue share of 56.95% in 2024.
• North America AI in cancer diagnostics market dominated in 2023 with the largest share of 54.74%.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Component
  • 1.1.2. Cancer type
  • 1.1.3. End use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component outlook
  • 2.2.2. Cancer type outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Artificial Intelligence In Cancer Diagnostics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. Artificial Intelligence In Cancer Diagnostics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
• 3.4. COVID-19 Impact
• 3.5. Case Study

Chapter 4. Artificial Intelligence In Cancer Diagnostics Market: Component Estimates & Trend Analysis

• 4.1. Component Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Artificial Intelligence In Cancer Diagnostics Market by Component Outlook
• 4.4. Software Solutions
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Hardware
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Artificial Intelligence In Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis

• 5.1. Cancer Type Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Artificial Intelligence In Cancer Diagnostics Market by Cancer Type Outlook
• 5.4. Breast Cancer
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Lung Cancer
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Prostate Cancer
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.7. Colorectal Cancer
  • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.8. Brain Tumor
  • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Artificial Intelligence In Cancer Diagnostics Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Artificial Intelligence In Cancer Diagnostics Market by End Use Outlook
• 6.4. Hospital
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Surgical Centers and Medical Institutes
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Artificial Intelligence In Cancer Diagnostics Market: Regional Estimates & Trend Analysis, By Component, By Cancer Type, By End Use

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Innovators
• 8.4. Vendor Landscape
  • 8.4.1. EarlySign
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Technology Type benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Cancer Center.ai
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Technology Type benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Microsoft
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Technology Type benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. FLATIRON HEALTH
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Technology Type benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. PathAI, Inc.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Technology Type benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Therapixel
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Technology Type benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Tempus AI, Inc.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Technology Type benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Paige AI Inc.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Technology Type benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Kheiron Medical Technologies Limited
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Technology Type benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. SkinVision
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Technology Type benchmarking
    • 8.4.10.4. Strategic initiatives